Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$14.22M$14.22Mderived+96.4% vs Q4 2017 Net Income$2.90M$2.90Mderived+517.3% vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$9,310,000+78.6% Operating Incomederived$2,756,000+1,937.3% Operating Cash Flowderived$2,633,000−11.3% Free Cash Flowderived$2,071,000−17.8% Margins · derivedGross margin65.5%−6.5 pt vs Q4 2017
Operating margin19.4%+17.5 pt vs Q4 2017
Net margin20.4%+13.9 pt vs Q4 2017
ended Dec 31, 2018 · filed Mar 12, 2019 · 71 d after period end